Comprehensive Genomic Profiling With Loss of Heterozygosity for Ovarian Cancer Treatment

Julia Elvin, MD, PhD, vice president and senior associate medical director, Foundation Medicine, discusses a study of comprehensive genomic profiling with loss of heterozygosity to identify therapeutically relevant subsets of ovarian cancer.